266
Corcept Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
499
FY23:
459
FY24:
472
FY25:
485
(positive)
Change from FY21 to FY25
millions USD
FY21:
157
FY22:
84.2
FY23:
163
FY24:
369
FY25:
351
Total assets
Change from FY21 to FY25
millions USD
FY21:
424
FY22:
583
FY23:
622
FY24:
841
FY25:
837
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
47.5
FY22:
72.5
FY23:
105
FY24:
141
FY25:
166
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.41
FY22:
9.10
FY23:
10.3
FY24:
20.2
FY25:
22.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
376
FY22:
502
FY23:
507
FY24:
680
FY25:
648
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
424
FY22:
583
FY23:
622
FY24:
841
FY25:
837
All amounts in millions USD